Prof. Weimin LiDean of West China School of Medicine,Sichuan University
Prof. Dr. Weimin Li has been a physician and researcher at the Respiratory
Department of West China Hospital since he got his master’s in 1991 and later doctoral degree in 1995 at the West China University of Medical Sciences, which was merged with Sichuan University in 1999. His specialty and research interest includes diagnosis and treatment of respiratory diseases, especially of pulmonary infection and lung cancer. Prof. Li has been PI for more than ten research projects supported by the National Natural Science Foundation of China, the Sci-tech Pillar Project of the Eleventh Five-year Plan of China, and by the governments of Chengdu and Sichuan Province, China. He has published more than 100 research articles, and is the editor-in-chief of West China Medical Journal and the associate editor-in-chief of Chinese Journal of Lung Disease. Prof. Weimin Li is the Vice Chairman of the Chinese Society of Clinical Precision Medicine.
Prof. Kang Zhang
Affiliation: Chief of Ophthalmic Genetics at the University of California San Diego
Dr. Zhang obtained his M.D. with Magna Cum Laude honors from the Harvard Medical School and MIT joint program and his Ph.D. in genetics from Harvard University. He completed his residency in ophthalmology at Wilmer Eye Institute at Johns Hopkins University and his retina fellowship at University of Utah. He was a faculty member at Johns Hopkins University, Cleveland Clinic Foundation, and the University of Utah. Dr. Zhang is currently the founding director of the Institute for Genomic Medicine, co-director of the Bio Materials and Tissue Engineering Center at the Institute of Engineering in Medicine, Professor of Ophthalmology and Genetics, and Chief of Ophthalmic Genetics at the University of California San Diego. Dr. Zhang’s clinical and research spans novel disease gene targets and treatments, gene- and stem cell-based therapies, 3D bioprinting and tissue engineering, drug discovery and delivery, aging and epigenetics, and clinical trials. He has published more than 150 papers in international journals including Nature, Science, Cell, PNAS, New Engl J Med, and Mol Cell. He has numerous grants from the National Institutes of Health and other foundations. His discovery that HTRA1 is a major susceptibility gene for age-related macular degeneration is listed as one of “top-ten breakthroughs in 2006” by Science.
Prof. Sherman Weissman
Affiliation: the Sterling Professor of Genetics at the Yale School of Medicine
After attending Harvard Medical School, Weissman interned at Boston City Hospital and was a research fellow with the National Institutes of Health and the National Cancer Institute before taking a faculty position at Yale. Weissman mentored Francis Collins, the director of the NIH, during Collins's postdoctoral fellowship at Yale. In 1978, Weissman published the complete nucleic acid sequence of the SV40 genome. Weissman was elected to the National Academy of Sciences in 1983.
Xinyuan Fu, National University of Singapore (Singapore)
Geoffrey S. Ginsburg, Duke University (USA)
Xin Lu, University of Oxford (UK)
Xinghua Pan, Yale Medical School (USA)
Simon Travis, University of Oxford (UK)
Chen Wang, China-Japan Friendship Hospital (China)
Cunyu Wang, Academician of CAE, University of California Los Angeles (USA)
Yuquan Wei, Academician of CAS, Sichuan University (China)
Weizhong Li, Sun Yat-sen University (China)
Bairong Shen, West China Hospital, Sichuan University (China)
Yilong Wu, Guangdong General Hospital (China)
Jinming Yu, Shandong Cancer Hospital & Institute (China)
Hu Zhang, West China Hospital, Sichuan University (China)
Shuyang Zhang, Peking Union Medical College Hospital (China)
Wengeng Zhang, West China Hospital, Sichuan University (China)